Randomized Phase III Study of Alisertib or Investigator's Choice (Selected Single Agent) in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma
一项随机III期研究,比较Alisertib或研究者选择的单药治疗复发或难治性外周T细胞淋巴瘤患者的疗效
期刊:Journal of Clinical Oncology
影响因子:41.9
doi:10.1200/JCO.18.00899
O'Connor, Owen A; Özcan, Muhit; Jacobsen, Eric D; Roncero, Josep M; Trotman, Judith; Demeter, Judit; Masszi, Tamás; Pereira, Juliana; Ramchandren, Radhakrishnan; Beaven, Anne; Caballero, Dolores; Horwitz, Steven M; Lennard, Anne; Turgut, Mehmet; Hamerschlak, Nelson; d'Amore, Francesco A; Foss, Francine; Kim, Won-Seog; Leonard, John P; Zinzani, Pier Luigi; Chiattone, Carlos S; Hsi, Eric D; Trümper, Lorenz; Liu, Hua; Sheldon-Waniga, Emily; Ullmann, Claudio Dansky; Venkatakrishnan, Karthik; Leonard, E Jane; Shustov, Andrei R